BLOO7 schreef op 3 juni 2019 09:48:
Reklaam gaan maken:
June 05, 2019
Jefferies Healthcare Conference
New York, US
June 11, 2019
Goldman Sachs Healthcare Conference
Palos Verdes, USwww.gilead.com/news-and-press/press-r...
data on filgotinib, an investigational, oral, selective JAK1 inhibitor, will be presented at the Annual European Congress of Rheumatology (EULAR 2019) in Madrid, Spain, on June 12-15, 2019.